Shandong Boan Biotechnology Company., Limited. Class H (HK:6955)
:6955
Want to see HK:6955 full AI Analyst Report?
Comparison Results
Shandong Boan Biotechnology Company., Limited. Class H
HK$7.01
HK$3.93B
406.71
-44.91%
―
Alphamab Oncology
HK$11.90
HK$8.33B
-15.87
-2.00%
1 Buy
0 Hold
0 Sell
Moderate Buy
Ascletis Pharma, Inc.
HK$18.48
HK$15.76B
-27.65
115.86%
1 Buy
1 Hold
0 Sell
Moderate Buy
HBM Holdings Ltd.
HK$12.08
HK$10.47B
13.52
22.58%
2 Buy
0 Hold
0 Sell
Moderate Buy
Abbisko Cayman Limited
HK$13.02
HK$7.24B
―
12.71%
3 Buy
0 Hold
0 Sell
Strong Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.70
HK$20.67B
25.33
257.14%
―
Performance Comparison
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
6.06
-4.70
-43.68%
HK:9966
Alphamab Oncology
8.80
-0.18
-2.00%
HK:1672
Ascletis Pharma, Inc.
15.11
8.49
128.25%
HK:2142
HBM Holdings Ltd.
11.89
2.74
29.95%
HK:2256
Abbisko Cayman Limited
9.93
1.16
13.23%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
51.00
36.34
247.89%